Zimbabwe to roll out long-acting HIV prevention drug, 46,500 set to benefit

Zimbabwe is dumping 46,500 people onto Lenacapavir next month, which is this twice-a-year shot that keeps HIV away without needing daily pills. Getrude Ncube from the national prevention crew said they picked districts like Bulawayo, Gweru, and Harare based on where new infections keep spiking, and the health minister announced everything five days after approval came through. The country became the third spot in Africa to greenlight the drug.

They are rolling out the injectable to women who struggle with consistent pill schedules, sex workers, and pregnant people in areas where treatment coverage is garbage. The ministry built an AI chatbot called Vimbai that helps people figure out testing and prevention options, and it is already running in Gweru with decent engagement numbers.

Survey data showed that awareness of prevention drugs sits under 50 percent, even though oral options have been around since way back, so digital outreach is getting pushed hard before the doses arrive.
 

Attachments

  • Zimbabwe to roll out long-acting HIV prevention drug, 46,500 set to benefit.webp
    Zimbabwe to roll out long-acting HIV prevention drug, 46,500 set to benefit.webp
    51.2 KB · Views: 45

Trending content

Sponsored

Top